Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVANZ Mite Mix Immunotherapy Tolerability
NCT01568190Phase 3Completed
- Sponsor
- ALK-Abelló
- Start
- Dec 2011
- Primary completion
- Jul 2012
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of House dust mite allergen extract in allergic rhinitis (AR), sponsored by ALK-Abelló. Started Dec 2011; status: completed.
02
Drugs
House dust mite allergen extract
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT01568190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01568190.